These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 39288289)

  • 1. Integrated stress response (ISR) activation and apoptosis through HRI kinase by PG3 and other p53 pathway-restoring cancer therapeutics.
    Tian X; El-Deiry WS
    Oncotarget; 2024 Sep; 15():614-633. PubMed ID: 39288289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P53-independent partial restoration of the p53 pathway in tumors with mutated p53 through ATF4 transcriptional modulation by ERK1/2 and CDK9.
    Tian X; Ahsan N; Lulla A; Lev A; Abbosh P; Dicker DT; Zhang S; El-Deiry WS
    Neoplasia; 2021 Mar; 23(3):304-325. PubMed ID: 33582407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal apoptosis induced by endoplasmic reticulum stress is regulated by ATF4-CHOP-mediated induction of the Bcl-2 homology 3-only member PUMA.
    Galehdar Z; Swan P; Fuerth B; Callaghan SM; Park DS; Cregan SP
    J Neurosci; 2010 Dec; 30(50):16938-48. PubMed ID: 21159964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of nutlin-induced apoptosis in multiple myeloma: evidence for p53-transcription-dependent and -independent pathways.
    Saha MN; Jiang H; Chang H
    Cancer Biol Ther; 2010 Sep; 10(6):567-78. PubMed ID: 20595817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2α kinases.
    Kline CL; Van den Heuvel AP; Allen JE; Prabhu VV; Dicker DT; El-Deiry WS
    Sci Signal; 2016 Feb; 9(415):ra18. PubMed ID: 26884600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin induced apoptosis of ovarian cancer A2780s cells by activation of ERK/p53/PUMA signals.
    Song H; Wei M; Liu W; Shen S; Li J; Wang L
    Histol Histopathol; 2018 Jan; 33(1):73-79. PubMed ID: 28287251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of a potent activator of p53-independent cellular senescence via a small-molecule screen for modifiers of the integrated stress response.
    Sayers CM; Papandreou I; Guttmann DM; Maas NL; Diehl JA; Witze ES; Koong AC; Koumenis C
    Mol Pharmacol; 2013 Mar; 83(3):594-604. PubMed ID: 23229510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of eIF2α suppresses cisplatin-induced p53 activation and apoptosis by attenuating oxidative stress via ATF4-mediated HO-1 expression in human renal proximal tubular cells.
    Ju SM; Jo YS; Jeon YM; Pae HO; Kang DG; Lee HS; Bae JS; Jeon BH
    Int J Mol Med; 2017 Dec; 40(6):1957-1964. PubMed ID: 29039478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A sustained deficiency of mitochondrial respiratory complex III induces an apoptotic cell death through the p53-mediated inhibition of pro-survival activities of the activating transcription factor 4.
    Evstafieva AG; Garaeva AA; Khutornenko AA; Klepikova AV; Logacheva MD; Penin AA; Novakovsky GE; Kovaleva IE; Chumakov PM
    Cell Death Dis; 2014 Nov; 5(11):e1511. PubMed ID: 25375376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pazopanib, a novel multi-kinase inhibitor, shows potent antitumor activity in colon cancer through PUMA-mediated apoptosis.
    Zhang L; Wang H; Li W; Zhong J; Yu R; Huang X; Wang H; Tan Z; Wang J; Zhang Y
    Oncotarget; 2017 Jan; 8(2):3289-3303. PubMed ID: 27924057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting oncogenic signaling by sorafenib activates PUMA via GSK3β and NF-κB to suppress tumor cell growth.
    Dudgeon C; Peng R; Wang P; Sebastiani A; Yu J; Zhang L
    Oncogene; 2012 Nov; 31(46):4848-58. PubMed ID: 22286758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Response to Non-genotoxic Activation of p53 by Nutlin3a Is Driven by PUMA-Mediated Apoptosis in Lymphoma Cells.
    Valente LJ; Aubrey BJ; Herold MJ; Kelly GL; Happo L; Scott CL; Newbold A; Johnstone RW; Huang DC; Vassilev LT; Strasser A
    Cell Rep; 2016 Mar; 14(8):1858-66. PubMed ID: 26904937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NOXA upregulation by the prohibitin-binding compound fluorizoline is transcriptionally regulated by integrated stress response-induced ATF3 and ATF4.
    Núñez-Vázquez S; Sánchez-Vera I; Saura-Esteller J; Cosialls AM; Noisier AFM; Albericio F; Lavilla R; Pons G; Iglesias-Serret D; Gil J
    FEBS J; 2021 Feb; 288(4):1271-1285. PubMed ID: 32648994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant p53 drives cancer chemotherapy resistance due to loss of function on activating transcription of PUMA.
    Huang Y; Liu N; Liu J; Liu Y; Zhang C; Long S; Luo G; Zhang L; Zhang Y
    Cell Cycle; 2019 Dec; 18(24):3442-3455. PubMed ID: 31726940
    [No Abstract]   [Full Text] [Related]  

  • 15. Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1.
    Ray RM; Bhattacharya S; Johnson LR
    Apoptosis; 2011 Jan; 16(1):35-44. PubMed ID: 20812030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capsaicin Induces ATF4 Translation with Upregulation of CHOP, GADD34 and PUMA.
    Moriguchi M; Watanabe T; Fujimuro M
    Biol Pharm Bull; 2019; 42(8):1428-1432. PubMed ID: 31366879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAT-RasGAP317-326 requires p53 and PUMA to sensitize tumor cells to genotoxins.
    Michod D; Widmann C
    Mol Cancer Res; 2007 May; 5(5):497-507. PubMed ID: 17510315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions.
    Garufi A; Pistritto G; Baldari S; Toietta G; Cirone M; D'Orazi G
    J Exp Clin Cancer Res; 2017 Sep; 36(1):126. PubMed ID: 28893313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pseudo-caspase FLIP(L) regulates cell fate following p53 activation.
    Lees A; McIntyre AJ; Crawford NT; Falcone F; McCann C; Holohan C; Quinn GP; Roberts JZ; Sessler T; Gallagher PF; Gregg GMA; McAllister K; McLaughlin KM; Allen WL; Egan LJ; Ryan AE; Labonte-Wilson MJ; Dunne PD; Wappett M; Coyle VM; Johnston PG; Kerr EM; Longley DB; McDade SS
    Proc Natl Acad Sci U S A; 2020 Jul; 117(30):17808-17819. PubMed ID: 32661168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhythmic control of the ARF-MDM2 pathway by ATF4 underlies circadian accumulation of p53 in malignant cells.
    Horiguchi M; Koyanagi S; Hamdan AM; Kakimoto K; Matsunaga N; Yamashita C; Ohdo S
    Cancer Res; 2013 Apr; 73(8):2639-49. PubMed ID: 23580573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.